Apogenix Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Liquidation

Apogenix General Information

Description

Developer of immuno-oncology therapeutics designed to treat cancer and other malignant diseases. The company's platform targets critical pathways involved in the proliferation, migration, and apoptosis of diseased cells, boosting the immune response cycle to strengthen and prolong the anti-tumor immune response, enabling patients to develop anti-tumor immune cells that can fight back if a tumor reoccurs.

Contact Information

Formerly Known As
Apogenix Biotechnology
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Im Neuenheimer Feld 584
  • 69120 Heidelberg
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Im Neuenheimer Feld 584
  • 69120 Heidelberg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apogenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 31-Dec-2025 Completed Bankruptcy: Liquidation
9. Later Stage VC 09-Dec-2021 Completed Clinical Trials - Phase 2
8. Grant 16-Feb-2016 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series C) 05-Jan-2012 Completed Clinical Trials - Phase 2
6. Grant 03-Jan-2012 Completed Clinical Trials - Phase 2
5. Grant 29-Jul-2009 Completed Startup
4. Grant 19-Sep-2008 Completed Startup
3. Early Stage VC (Series B) 30-Apr-2008 Completed Startup
2. Grant 12-Mar-2007 $1.97M Completed Startup
1. Early Stage VC 01-Nov-2005 Completed Startup
To view Apogenix’s complete valuation and funding history, request access »

Apogenix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immuno-oncology therapeutics designed to treat cancer and other malignant diseases. The company's platform
Drug Discovery
Heidelberg, Germany
30 As of 2023

Cambridge, United Kingdom
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Apogenix Competitors (35)

One of Apogenix’s 35 competitors is Artios, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Artios Venture Capital-Backed Cambridge, United Kingdom
Gylden Pharma Venture Capital-Backed Abingdon, United Kingdom
Verseau Therapeutics Venture Capital-Backed Auburndale, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
Iovance Biotherapeutics Corporation San Carlos, CA
You’re viewing 5 of 35 competitors. Get the full list »

Apogenix Patents

Apogenix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023088889-A1 Cd137 ligands Inactive 16-Nov-2021
WO-2023088876-A1 Multi-specific immune modulators Inactive 16-Nov-2021
EP-4149964-A2 Multi-specific immune modulators Inactive 15-May-2020
US-20230212260-A1 Multi-specific immune modulators Inactive 15-May-2020
WO-2021229103-A2 Multi-specific immune modulators Inactive 15-May-2020 C07K14/70575
To view Apogenix’s complete patent history, request access »

Apogenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apogenix FAQs

  • When was Apogenix founded?

    Apogenix was founded in 2005.

  • Where is Apogenix headquartered?

    Apogenix is headquartered in Heidelberg, Germany.

  • What is the size of Apogenix?

    Apogenix has 30 total employees.

  • What industry is Apogenix in?

    Apogenix’s primary industry is Drug Discovery.

  • Is Apogenix a private or public company?

    Apogenix is a Private company.

  • What is Apogenix’s current revenue?

    The current revenue for Apogenix is .

  • How much funding has Apogenix raised over time?

    Apogenix has raised $76.5M.

  • Who are Apogenix’s competitors?

    Artios, Gylden Pharma, Verseau Therapeutics, Kite Pharma, and Iovance Biotherapeutics are some of the 35 competitors of Apogenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process